Strain Profile
Save
Streptococcus agalactiae
◔
Human-origin
Where this strain was first isolated, curated from the literature and culture-collection catalogs. It describes provenance only — not suitability, and not benefit.
How we classify this →
Sequenced
Whether a public genome assembly is linked for this strain. Without one the genome screens cannot run. It is not a verdict on the organism.
How we classify this →
Public genome assembly available
Streptococcus agalactiae (Group B Streptococcus, or GBS) is a pathogenic bacterium — not a probiotic organism — clinically significant as a leading cause of neonatal infections and a complication of pregnancy. It is routinely screened for in late pregnancy and is not used in any supplementation context. No evidence for a beneficial health role appears in the indexed literature for this species.
Discussion
Be the first to comment.
Sign in to join the discussion.
No comments yet.